DiaMedica Therapeutics Inc.
Cash Flow Statement
| Line Item | Jun 2026 | Mar 2026 | Sep 2025 | Jun 2025 | Mar 2025 | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-10.1M | $-10.0M | $-8.6M | $-7.7M | $-7.7M | $-6.3M | $-5.1M | $-5.2M |
| Depreciation & Amortization | — | — | — | — | — | — | — | — |
| Depreciation | — | $11.0K | — | — | $11.0K | — | — | $8.0K |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | — | $822.0K | — | — | $867.0K | — | — | $488.0K |
| Net Cash from Operating Activities | $-8.1M | $-9.1M | $-6.6M | $-7.6M | $-7.1M | $-4.5M | $-4.5M | $-6.7M |
| Investing Activities | ||||||||
| Capital Expenditures | $3.0K | $8.0K | $16.0K | $6.0K | $12.0K | $9.0K | $0 | $9.0K |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | — | $-2.1M | — | — | $6.6M | — | — | $4.2M |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | — | $417.0K | — | — | $91.0K | — | — | $-1.0K |
| Net Change in Cash | — | $-10.8M | — | — | $-436.0K | — | — | $-2.4M |
| Free Cash Flow | $-8.1M | $-9.1M | $-6.6M | $-7.6M | $-7.2M | $-4.5M | $-4.5M | $-6.7M |